Literature DB >> 17073757

The androgen receptor DNA-binding domain determines androgen selectivity of transcriptional response.

G Verrijdt1, T Tanner, U Moehren, L Callewaert, A Haelens, F Claessens.   

Abstract

The AR (androgen receptor) is a hormone-dependent transcription factor that translates circulating androgen hormone levels into a physiological cellular response by directly regulating the expression of its target genes. It is the key molecule in e.g. the development and maintenance of the male sexual characteristics, spermatocyte production and prostate gland development and growth. It is also a major factor in the onset and maintenance of prostate cancer and a first target for pharmaceutical action against the further proliferation of prostate cancer cells. The AR is a member of the steroid hormone receptors, a group of steroid-inducible transcription factors sharing an identical consensus DNA-binding motif. The problem of how specificity in gene activation is achieved among the different members of this nuclear receptor subfamily is still unclear. In this report, we describe our investigations on how the AR can specifically activate its target genes, while the other steroid hormone receptors do not, despite having the same consensus monomeric DNA-binding motif. In this respect, we describe how the AR interacts with a newly identified class of steroid-response elements to which only the AR and not, for example, the glucocorticoid receptor can bind.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17073757     DOI: 10.1042/BST0341089

Source DB:  PubMed          Journal:  Biochem Soc Trans        ISSN: 0300-5127            Impact factor:   5.407


  15 in total

Review 1.  Androgen receptor and miR-206 regulation in prostate cancer.

Authors:  Fu Y Chua; Brian D Adams
Journal:  Transcription       Date:  2017-06-09

2.  Hormone depletion-insensitivity of prostate cancer cells is supported by the AR without binding to classical response elements.

Authors:  Mesfin Gonit; Juan Zhang; Marcela d'Alincourt Salazar; Hongjuan Cui; Aymen Shatnawi; Robert Trumbly; Manohar Ratnam
Journal:  Mol Endocrinol       Date:  2011-02-17

3.  Different types of androgen receptor mutations in patients with complete androgen insensitivity syndrome.

Authors:  Jialiang Shao; Jiangang Hou; Bingkun Li; Dongyang Li; Ning Zhang; Xiang Wang
Journal:  Intractable Rare Dis Res       Date:  2015-02

4.  Intronic DNA elements regulate androgen-dependent expression of the murine Nkx3.1 gene.

Authors:  Chinatsu Kojima; Yan Zhang; Warren E Zimmer
Journal:  Gene Expr       Date:  2010

Review 5.  Rationale for the development of alternative forms of androgen deprivation therapy.

Authors:  Sangeeta Kumari; Dhirodatta Senapati; Hannelore V Heemers
Journal:  Endocr Relat Cancer       Date:  2017-05-31       Impact factor: 5.678

6.  Challenges in clinical and laboratory diagnosis of androgen insensitivity syndrome: a case report.

Authors:  Caroline Oa Melo; Daniela M Silva; Aparecido D da Cruz
Journal:  J Med Case Rep       Date:  2011-09-08

7.  Sequence analysis of p53 response-elements suggests multiple binding modes of the p53 tetramer to DNA targets.

Authors:  Buyong Ma; Yongping Pan; Jie Zheng; Arnold J Levine; Ruth Nussinov
Journal:  Nucleic Acids Res       Date:  2007-04-16       Impact factor: 16.971

8.  Androgen receptor uses relaxed response element stringency for selective chromatin binding and transcriptional regulation in vivo.

Authors:  Biswajyoti Sahu; Päivi Pihlajamaa; Vanessa Dubois; Stefanie Kerkhofs; Frank Claessens; Olli A Jänne
Journal:  Nucleic Acids Res       Date:  2014-01-22       Impact factor: 16.971

9.  The fate of the duplicated androgen receptor in fishes: a late neofunctionalization event?

Authors:  Véronique Douard; Frédéric Brunet; Bastien Boussau; Isabelle Ahrens-Fath; Virginie Vlaeminck-Guillem; Bernard Haendler; Vincent Laudet; Yann Guiguen
Journal:  BMC Evol Biol       Date:  2008-12-18       Impact factor: 3.260

Review 10.  Diverse roles of androgen receptor (AR) domains in AR-mediated signaling.

Authors:  Frank Claessens; Sarah Denayer; Nora Van Tilborgh; Stefanie Kerkhofs; Christine Helsen; Annemie Haelens
Journal:  Nucl Recept Signal       Date:  2008-06-27
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.